{"transactions":[{"id":751312,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-03T22:05:03.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":11182,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests on the earlier of June 1, 2027 or the Issuer's 2027 annual meeting of stockholders."}],"balance_after":11182,"derivative":{"exercise_price":5.43,"expiration_date":"2036-06-01","underlying":"Common Stock","underlying_shares":11182},"source":{"system":"sec-edgar","filing":"0001566080-26-000002","document":"form4-06032026_100659.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235912/000156608026000002/form4-06032026_100659.xml","form_type":"4"}},{"id":751311,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-03T22:05:03.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":8720,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Vests on the earlier of June 1, 2027 or the Issuer's 2027 annual meeting of stockholders."}],"balance_after":8720,"source":{"system":"sec-edgar","filing":"0001566080-26-000002","document":"form4-06032026_100659.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235912/000156608026000002/form4-06032026_100659.xml","form_type":"4"}},{"id":1121085,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-05T21:13:11.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":19554,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests on the earlier of June 3, 2026 or the Issuer's 2026 annual meeting of stockholders."}],"balance_after":19554,"derivative":{"exercise_price":6.76,"expiration_date":"2035-06-03","underlying":"Common Stock","underlying_shares":19554},"source":{"system":"sec-edgar","filing":"0001415889-25-015807","document":"form4-06052025_090656.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235912/000141588925015807/form4-06052025_090656.xml","form_type":"4"}},{"id":1403298,"issuer":{"id":87417,"kind":"organization","name":"Silk Road Medical Inc","symbol":"SILK"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-09-18T20:48:35.000Z","date":"2024-09-17","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":23666,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Of the reported shares, 5,859 are represented by restricted stock units, or RSUs, each of which represents a contingent right to receive one share of Issuer common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Agreement and Plan of Merger dated June 17, 2024, between the Issuer, Boston Scientific Corporation and Seminole Merger Sub, Inc, (the \"Merger Agreement\"), each share of Issuer common stock was canceled and converted into the right to receive $27.50 per share in cash (the \"Merger Consideration\"), without interest and subject to applicable withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, each RSU was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the Merger Consideration and (ii) the aggregate number of shares underlying the RSUs, less applicable taxes and authorized deductions."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001140361-24-041421","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1397702/000114036124041421/form4.xml","form_type":"4"}},{"id":1413673,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-09-05T20:44:02.000Z","date":"2024-09-03","kind":"grant","planned":false,"acquired":true,"shares":36136,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests as to one-third of the shares on each annual anniversary of the date of grant."}],"balance_after":36136,"derivative":{"exercise_price":9.05,"expiration_date":"2034-09-02","underlying":"Common Stock","underlying_shares":36136},"source":{"system":"sec-edgar","filing":"0001415889-24-022938","document":"form4-09052024_080958.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235912/000141588924022938/form4-09052024_080958.xml","form_type":"4"}},{"id":1471788,"issuer":{"id":87417,"kind":"organization","name":"Silk Road Medical Inc","symbol":"SILK"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-21T18:42:25.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":5859,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are represented by restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one share of SILK common stock. All of the RSUs vest on the earlier of (i) the one-year anniversary of the date the award is granted or (ii) the day prior to the date of the Issuer's 2025 annual meeting of stockholders, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":23666,"source":{"system":"sec-edgar","filing":"0001593968-24-000882","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1397702/000159396824000882/primary_01.xml","form_type":"4"}},{"id":1496350,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-31T20:28:24.000Z","date":"2024-05-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1733,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports the disposition of securities pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of April 4, 2024, by and among the Issuer, Johnson & Johnson (\"J&J\"), and Sweep Merger Sub, Inc., a wholly owned subsidiary of J&J (\"Merger Sub\"), pursuant to which Merger Sub merged with and into the Issuer (the \"Merger\"), effective as of the effective time of the Merger (the \"Effective Time\"), with the Issuer surviving the Merger as a wholly owned subsidiary of J&J. As a result of the Merger, at the Effective Time, each outstanding share of common stock, par value $0.001 per share, of the Issuer (\"Common Stock\") outstanding immediately prior to the Effective Time (excluding Excluded Shares and any Dissenting Company Shares, each as defined in the Merger Agreement) was automatically converted into the right to receive $335.00 in cash (the \"Merger Consideration\"),"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from Footnote 1) without interest and less any applicable withholding taxes.  Additionally, pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit (\"RSU\") outstanding immediately prior to the Effective Time, whether vested or unvested, was cancelled and converted into the right to receive a cash amount, without interest and less any applicable withholding taxes, equal to the product of (i) the aggregate number of shares of Common Stock underlying such RSU immediately prior to the Effective Time and (ii) the Merger Consideration."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001642545-24-000113","document":"wk-form4_1717187293.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566080/000164254524000113/wk-form4_1717187293.xml","form_type":"4"}},{"id":1588769,"issuer":{"id":87417,"kind":"organization","name":"Silk Road Medical Inc","symbol":"SILK"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-03-07T06:01:30.000Z","date":"2024-03-05","kind":"purchase","planned":false,"acquired":true,"shares":11700,"price":16.99,"value":198783.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at price ranging from $16.92 to $17.01. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":17807,"source":{"system":"sec-edgar","filing":"0001593968-24-000450","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1397702/000159396824000450/primary_01.xml","form_type":"4"}},{"id":1844923,"issuer":{"id":87417,"kind":"organization","name":"Silk Road Medical Inc","symbol":"SILK"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"director":true}}],"security":"Option (right to buy)","published_at":"2023-06-23T17:36:28.000Z","date":"2023-06-21","kind":"grant","planned":false,"acquired":true,"shares":3566,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The shares subject to the options represent cash retainer that the Reporting Person elected to receive in the form of stock options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One fourth of the shares subject to the option shall vest on each of September 5, 2023, December 5, 2023, March 5, 2024, and the date of the Issuer's 2024 annual meeting of stockholders, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":3566,"derivative":{"exercise_price":33.57,"exercise_date":"2023-09-05","expiration_date":"2033-06-21","underlying":"Common Stock","underlying_shares":3566},"source":{"system":"sec-edgar","filing":"0001593968-23-001036","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1397702/000159396823001036/primary_01.xml","form_type":"4"}},{"id":1844922,"issuer":{"id":87417,"kind":"organization","name":"Silk Road Medical Inc","symbol":"SILK"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-06-23T17:36:28.000Z","date":"2023-06-21","kind":"grant","planned":false,"acquired":true,"shares":4691,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are represented by restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one share of SILK common stock. All of the RSUs vest on the earlier of (i) the one-year anniversary of the date the award is granted or (ii) the day prior to the date of the Issuer's 2024 annual meeting of stockholders, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":6107,"source":{"system":"sec-edgar","filing":"0001593968-23-001036","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1397702/000159396823001036/primary_01.xml","form_type":"4"}},{"id":1853890,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-15T22:47:06.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":736,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1733,"source":{"system":"sec-edgar","filing":"0001209191-23-037552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566080/000120919123037552/doc4.xml","form_type":"4"}},{"id":1886464,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-18T22:37:53.000Z","date":"2023-05-16","kind":"grant","planned":false,"acquired":true,"shares":997,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The shares subject to the restricted stock units vest in equal annual installments over three years commencing on May 16, 2023, subject to the Reporting Person's continued service through each relevant vesting date."}],"balance_after":997,"source":{"system":"sec-edgar","filing":"0001209191-23-030800","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566080/000120919123030800/doc4.xml","form_type":"4"}},{"id":2233760,"issuer":{"id":87417,"kind":"organization","name":"Silk Road Medical Inc","symbol":"SILK"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2022-06-13T18:20:42.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":5195,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"All of the shares subject to the option shall vest on the earlier of (i) the one-year anniversary of the date the award is granted or (ii) the day prior to the date of the Issuer's 2023 annual meeting of stockholders, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":5195,"derivative":{"exercise_price":36.9,"exercise_date":"2023-06-05","expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":5195},"source":{"system":"sec-edgar","filing":"0001593968-22-001122","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1397702/000159396822001122/primary_01.xml","form_type":"4"}},{"id":2233759,"issuer":{"id":87417,"kind":"organization","name":"Silk Road Medical Inc","symbol":"SILK"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2022-06-13T18:20:42.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":3214,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The shares subject to the options represent cash retainer that the Reporting Person elected to receive in the form of stock options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One fourth of the shares subject to the option shall vest on each of September 5, 2022, December 5, 2022, March 5, 2023, and the date of the Issuer's 2023 annual meeting of stockholders, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":3214,"derivative":{"exercise_price":36.9,"exercise_date":"2022-09-05","expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":3214},"source":{"system":"sec-edgar","filing":"0001593968-22-001122","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1397702/000159396822001122/primary_01.xml","form_type":"4"}},{"id":2233758,"issuer":{"id":87417,"kind":"organization","name":"Silk Road Medical Inc","symbol":"SILK"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-13T18:20:42.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":846,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are represented by restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one share of SILK common stock.  All of the RSUs vest on the earlier of (i) the one-year anniversary of the date the award is granted or (ii) the day prior to the date of the Issuer's 2023 annual meeting of stockholders, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":1416,"source":{"system":"sec-edgar","filing":"0001593968-22-001122","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1397702/000159396822001122/primary_01.xml","form_type":"4"}},{"id":2660279,"issuer":{"id":87417,"kind":"organization","name":"Silk Road Medical Inc","symbol":"SILK"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2021-06-21T18:33:00.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":4066,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"All of the shares subject to the option shall vest on the earlier of (i) the one-year anniversary of the date the award is granted or (ii) the day prior to the date of the Issuer's 2022 annual meeting of stockholders, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":4066,"derivative":{"exercise_price":50.4,"exercise_date":"2022-06-05","expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":4066},"source":{"system":"sec-edgar","filing":"0001593968-21-001667","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1397702/000159396821001667/primary_01.xml","form_type":"4"}},{"id":2660278,"issuer":{"id":87417,"kind":"organization","name":"Silk Road Medical Inc","symbol":"SILK"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2021-06-21T18:33:00.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":2546,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The shares subject to the options represent cash retainer that the Reporting Person elected to receive in the form of stock options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One fourth of the shares subject to the option shall vest on each of September 5, 2021, December 5, 2021, March 5, 2022, and the date of the Issuer's 2022 annual meeting of stockholders, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":2546,"derivative":{"exercise_price":50.4,"exercise_date":"2021-09-05","expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":2546},"source":{"system":"sec-edgar","filing":"0001593968-21-001667","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1397702/000159396821001667/primary_01.xml","form_type":"4"}},{"id":2660277,"issuer":{"id":87417,"kind":"organization","name":"Silk Road Medical Inc","symbol":"SILK"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-21T18:33:00.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":570,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are represented by restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one share of SILK common stock.  All of the RSUs vest on the earlier of (i) the one-year anniversary of the date the award is granted or (ii) the day prior to the date of the Issuer's 2022 annual meeting of stockholders, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":570,"source":{"system":"sec-edgar","filing":"0001593968-21-001667","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1397702/000159396821001667/primary_01.xml","form_type":"4"}},{"id":2913381,"issuer":{"id":87417,"kind":"organization","name":"Silk Road Medical Inc","symbol":"SILK"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2021-01-07T19:14:18.000Z","date":"2021-01-05","kind":"grant","acquired":true,"shares":1023,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares subject to the options represent cash retainer that the Reporting Person elected to receive in the form of stock options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One third of the shares subject to the option shall vest on each of December 5, 2020, March 5, 2021, and the date of the Issuer's 2021 annual meeting of stockholders, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":1023,"derivative":{"exercise_price":60.69,"exercise_date":"2020-12-05","expiration_date":"2031-01-05","underlying":"Common Stock","underlying_shares":1023},"source":{"system":"sec-edgar","filing":"0001593968-21-000083","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1397702/000159396821000083/primary_01.xml","form_type":"4"}},{"id":2956317,"issuer":{"id":87417,"kind":"organization","name":"Silk Road Medical Inc","symbol":"SILK"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2020-12-04T17:50:54.000Z","date":"2020-12-03","kind":"grant","acquired":true,"shares":6723,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One third of the shares subject to the option shall vest on December 3, 2021 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":6723,"derivative":{"exercise_price":56.13,"exercise_date":"2021-12-03","expiration_date":"2030-12-03","underlying":"Common Stock","underlying_shares":6723},"source":{"system":"sec-edgar","filing":"0001593968-20-002330","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1397702/000159396820002330/primary_01.xml","form_type":"4"}},{"id":3225481,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Deferred Stock Units","published_at":"2020-03-05T21:10:29.000Z","date":"2020-03-03","kind":"exercise","acquired":false,"shares":3303,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on March 3, 2018, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on March 3, 2018, the first anniversary of the date of grant."}],"balance_after":6606,"derivative":{"expiration_date":"2022-03-03","underlying":"Common Stock","underlying_shares":3303},"source":{"system":"sec-edgar","filing":"0001225208-20-004422","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520820004422/doc4.xml","form_type":"4"}},{"id":3225480,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Common Stock","published_at":"2020-03-05T21:10:29.000Z","date":"2020-03-04","kind":"sale","acquired":false,"shares":1796,"price":38.05,"value":68337.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":80085,"source":{"system":"sec-edgar","filing":"0001225208-20-004422","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520820004422/doc4.xml","form_type":"4"}},{"id":3225479,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Common Stock","published_at":"2020-03-05T21:10:29.000Z","date":"2020-03-03","kind":"tax_withholding","acquired":false,"shares":1507,"price":37.23,"value":56105.61,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":81881,"source":{"system":"sec-edgar","filing":"0001225208-20-004422","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520820004422/doc4.xml","form_type":"4"}},{"id":3225478,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Common Stock","published_at":"2020-03-05T21:10:29.000Z","date":"2020-03-03","kind":"exercise","acquired":true,"shares":3303,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":83388,"source":{"system":"sec-edgar","filing":"0001225208-20-004422","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520820004422/doc4.xml","form_type":"4"}},{"id":3235025,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Common Stock","published_at":"2020-03-03T21:09:31.000Z","date":"2020-03-02","kind":"sale","acquired":false,"shares":15783,"price":37.2059,"value":587220.7197,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $36.90 to $37.61, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":80085,"source":{"system":"sec-edgar","filing":"0001225208-20-004146","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520820004146/doc4.xml","form_type":"4"}},{"id":3247288,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Performance Share Units","published_at":"2020-02-26T21:24:14.000Z","date":"2020-02-24","kind":"grant","acquired":true,"shares":10666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each performance share unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"shares","element":"transactionShares","label":"F4","text":"On February 21, 2019, the reporting person was awarded a target number of performance share units under the Company's 2019 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person would be based on the Company's 2019 adjusted free cash flow measured against its 2019 financial plan over the one-year performance period ending December 31, 2019 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 24, 2020, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined will vest in whole upon the completion of the individual service period that ends on December 31, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On February 21, 2019, the reporting person was awarded a target number of performance share units under the Company's 2019 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person would be based on the Company's 2019 adjusted free cash flow measured against its 2019 financial plan over the one-year performance period ending December 31, 2019 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 24, 2020, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined will vest in whole upon the completion of the individual service period that ends on December 31, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On February 21, 2019, the reporting person was awarded a target number of performance share units under the Company's 2019 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person would be based on the Company's 2019 adjusted free cash flow measured against its 2019 financial plan over the one-year performance period ending December 31, 2019 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 24, 2020, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined will vest in whole upon the completion of the individual service period that ends on December 31, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"On February 21, 2019, the reporting person was awarded a target number of performance share units under the Company's 2019 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person would be based on the Company's 2019 adjusted free cash flow measured against its 2019 financial plan over the one-year performance period ending December 31, 2019 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 24, 2020, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined will vest in whole upon the completion of the individual service period that ends on December 31, 2021."}],"balance_after":10666,"derivative":{"exercise_date":"2021-12-31","expiration_date":"2021-12-31","underlying":"Common Stock","underlying_shares":10666},"source":{"system":"sec-edgar","filing":"0001225208-20-003559","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520820003559/doc4.xml","form_type":"4"}},{"id":3247287,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Common Stock","published_at":"2020-02-26T21:24:14.000Z","date":"2020-02-25","kind":"sale","acquired":false,"shares":5658,"price":41.15,"value":232826.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":95868,"source":{"system":"sec-edgar","filing":"0001225208-20-003559","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520820003559/doc4.xml","form_type":"4"}},{"id":3254491,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Deferred Stock Units","published_at":"2020-02-24T22:07:28.000Z","date":"2020-02-23","kind":"exercise","acquired":false,"shares":3679,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"expiration_date":"2020-02-23","underlying":"Common Stock","underlying_shares":3679},"source":{"system":"sec-edgar","filing":"0001225208-20-003281","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520820003281/doc4.xml","form_type":"4"}},{"id":3254490,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Deferred Stock Units","published_at":"2020-02-24T22:07:28.000Z","date":"2020-02-22","kind":"exercise","acquired":false,"shares":3766,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant."}],"balance_after":3766,"derivative":{"expiration_date":"2021-02-22","underlying":"Common Stock","underlying_shares":3766},"source":{"system":"sec-edgar","filing":"0001225208-20-003281","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520820003281/doc4.xml","form_type":"4"}},{"id":3254489,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Deferred Stock Units","published_at":"2020-02-24T22:07:28.000Z","date":"2020-02-21","kind":"exercise","acquired":false,"shares":2959,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 21, 2020, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 21, 2020, the first anniversary of the date of grant."}],"balance_after":8880,"derivative":{"expiration_date":"2023-02-21","underlying":"Common Stock","underlying_shares":2959},"source":{"system":"sec-edgar","filing":"0001225208-20-003281","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520820003281/doc4.xml","form_type":"4"}},{"id":3254488,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Common Stock","published_at":"2020-02-24T22:07:28.000Z","date":"2020-02-23","kind":"tax_withholding","acquired":false,"shares":1678,"price":42.62,"value":71516.36,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":101526,"source":{"system":"sec-edgar","filing":"0001225208-20-003281","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520820003281/doc4.xml","form_type":"4"}},{"id":3254487,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Common Stock","published_at":"2020-02-24T22:07:28.000Z","date":"2020-02-23","kind":"exercise","acquired":true,"shares":3679,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":103204,"source":{"system":"sec-edgar","filing":"0001225208-20-003281","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520820003281/doc4.xml","form_type":"4"}},{"id":3254486,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Common Stock","published_at":"2020-02-24T22:07:28.000Z","date":"2020-02-22","kind":"tax_withholding","acquired":false,"shares":1718,"price":42.62,"value":73221.16,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":99525,"source":{"system":"sec-edgar","filing":"0001225208-20-003281","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520820003281/doc4.xml","form_type":"4"}},{"id":3254485,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Common Stock","published_at":"2020-02-24T22:07:28.000Z","date":"2020-02-22","kind":"exercise","acquired":true,"shares":3766,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":101243,"source":{"system":"sec-edgar","filing":"0001225208-20-003281","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520820003281/doc4.xml","form_type":"4"}},{"id":3254484,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Common Stock","published_at":"2020-02-24T22:07:28.000Z","date":"2020-02-21","kind":"tax_withholding","acquired":false,"shares":1350,"price":42.62,"value":57537.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":97477,"source":{"system":"sec-edgar","filing":"0001225208-20-003281","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520820003281/doc4.xml","form_type":"4"}},{"id":3254483,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Common Stock","published_at":"2020-02-24T22:07:28.000Z","date":"2020-02-21","kind":"exercise","acquired":true,"shares":2959,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":98827,"source":{"system":"sec-edgar","filing":"0001225208-20-003281","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520820003281/doc4.xml","form_type":"4"}},{"id":3264737,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-19T22:28:59.000Z","date":"2020-02-18","kind":"grant","acquired":true,"shares":46460,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant."}],"balance_after":46460,"derivative":{"exercise_price":42.16,"expiration_date":"2030-02-18","underlying":"Common Stock","underlying_shares":46460},"source":{"system":"sec-edgar","filing":"0001225208-20-002830","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520820002830/doc4.xml","form_type":"4"}},{"id":3264736,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Deferred Stock Units","published_at":"2020-02-19T22:28:59.000Z","date":"2020-02-18","kind":"grant","acquired":true,"shares":12452,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant."}],"balance_after":12452,"derivative":{"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":12452},"source":{"system":"sec-edgar","filing":"0001225208-20-002830","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520820002830/doc4.xml","form_type":"4"}},{"id":3264735,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Common Stock","published_at":"2020-02-19T22:28:59.000Z","date":"2020-02-19","kind":"sale","acquired":false,"shares":1757,"price":42.31,"value":74338.67,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":95868,"source":{"system":"sec-edgar","filing":"0001225208-20-002830","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520820002830/doc4.xml","form_type":"4"}},{"id":3268112,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Deferred Stock Units","published_at":"2020-02-18T21:07:52.000Z","date":"2020-02-15","kind":"exercise","acquired":false,"shares":3230,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant."}],"balance_after":9690,"derivative":{"expiration_date":"2023-02-15","underlying":"Common Stock","underlying_shares":3230},"source":{"system":"sec-edgar","filing":"0001225208-20-002600","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520820002600/doc4.xml","form_type":"4"}},{"id":3268111,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Common Stock","published_at":"2020-02-18T21:07:52.000Z","date":"2020-02-15","kind":"tax_withholding","acquired":false,"shares":1473,"price":42.31,"value":62322.63,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":97625,"source":{"system":"sec-edgar","filing":"0001225208-20-002600","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520820002600/doc4.xml","form_type":"4"}},{"id":3268110,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Common Stock","published_at":"2020-02-18T21:07:52.000Z","date":"2020-02-15","kind":"exercise","acquired":true,"shares":3230,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":99098,"source":{"system":"sec-edgar","filing":"0001225208-20-002600","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520820002600/doc4.xml","form_type":"4"}},{"id":3268109,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Common Stock","published_at":"2020-02-18T21:07:52.000Z","date":"2020-02-14","kind":"tax_withholding","acquired":false,"shares":11463,"price":42.31,"value":484999.53,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":95868,"source":{"system":"sec-edgar","filing":"0001225208-20-002600","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520820002600/doc4.xml","form_type":"4"}},{"id":3268108,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Common Stock","published_at":"2020-02-18T21:07:52.000Z","date":"2020-02-14","kind":"grant","acquired":true,"shares":27246,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 3, 2017, the reporting person was awarded a target number of performance share units under the Company's 2017 Total Shareholder Return Performance Share Program, the actual number of which to be earned by the reporting person would be based on the Company's total shareholder return performance percentile relative to that of the other companies in the S&P 500 Healthcare Index over the three annual performance cycles comprising the three-year period ended December 31, 2019 and subject to the completion of the concurrent three-year individual service period. On February 14, 2020, the number of the target performance share units as to which the performance criteria had been satisfied was determined and the individual service period was satisfied."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":107331,"source":{"system":"sec-edgar","filing":"0001225208-20-002600","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520820002600/doc4.xml","form_type":"4"}},{"id":3319962,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Common Stock","published_at":"2020-01-06T21:12:32.000Z","date":"2020-01-03","kind":"sale","acquired":false,"shares":11036,"price":44.52,"value":491322.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":80057,"source":{"system":"sec-edgar","filing":"0001225208-20-000514","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520820000514/doc4.xml","form_type":"4"}},{"id":3324839,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Performance Share Units","published_at":"2020-01-03T21:18:36.000Z","date":"2020-01-01","kind":"exercise","acquired":false,"shares":16117,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each performance share unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"shares","element":"transactionShares","label":"F1","text":"On February 28, 2017, the reporting person was awarded a target number of performance share units under the Company's 2017 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person based on the Company's 2017 adjusted free cash flow measured against its 2017 financial plan over the one-year performance period ending December 31, 2017 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 12, 2018, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The Performance Share Units so determined vested in whole upon the completion of the individual service period that ended on December 31, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 28, 2017, the reporting person was awarded a target number of performance share units under the Company's 2017 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person based on the Company's 2017 adjusted free cash flow measured against its 2017 financial plan over the one-year performance period ending December 31, 2017 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 12, 2018, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The Performance Share Units so determined vested in whole upon the completion of the individual service period that ended on December 31, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On February 28, 2017, the reporting person was awarded a target number of performance share units under the Company's 2017 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person based on the Company's 2017 adjusted free cash flow measured against its 2017 financial plan over the one-year performance period ending December 31, 2017 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 12, 2018, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The Performance Share Units so determined vested in whole upon the completion of the individual service period that ended on December 31, 2019."}],"balance_after":0,"derivative":{"exercise_date":"2019-12-31","expiration_date":"2019-12-31","underlying":"Common Stock","underlying_shares":16117},"source":{"system":"sec-edgar","filing":"0001225208-20-000289","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520820000289/doc4.xml","form_type":"4"}},{"id":3324838,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Common Stock","published_at":"2020-01-03T21:18:36.000Z","date":"2020-01-01","kind":"tax_withholding","acquired":false,"shares":5081,"price":45.22,"value":229762.82,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":91093,"source":{"system":"sec-edgar","filing":"0001225208-20-000289","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520820000289/doc4.xml","form_type":"4"}},{"id":3324837,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Common Stock","published_at":"2020-01-03T21:18:36.000Z","date":"2020-01-01","kind":"exercise","acquired":true,"shares":16117,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 28, 2017, the reporting person was awarded a target number of performance share units under the Company's 2017 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person based on the Company's 2017 adjusted free cash flow measured against its 2017 financial plan over the one-year performance period ending December 31, 2017 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 12, 2018, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The Performance Share Units so determined vested in whole upon the completion of the individual service period that ended on December 31, 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":96174,"source":{"system":"sec-edgar","filing":"0001225208-20-000289","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520820000289/doc4.xml","form_type":"4"}},{"id":3620833,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Deferred Stock Units","published_at":"2019-03-04T21:29:41.000Z","date":"2019-03-03","kind":"exercise","acquired":false,"shares":3302,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on March 3, 2018, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on March 3, 2018, the first anniversary of the date of grant."}],"balance_after":9909,"derivative":{"expiration_date":"2022-03-03","underlying":"Common Stock","underlying_shares":3302},"source":{"system":"sec-edgar","filing":"0001225208-19-004340","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520819004340/doc4.xml","form_type":"4"}},{"id":3620832,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Common Stock","published_at":"2019-03-04T21:29:41.000Z","date":"2019-03-03","kind":"tax_withholding","acquired":false,"shares":1506,"price":40.75,"value":61369.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":79368,"source":{"system":"sec-edgar","filing":"0001225208-19-004340","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520819004340/doc4.xml","form_type":"4"}},{"id":3620831,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Common Stock","published_at":"2019-03-04T21:29:41.000Z","date":"2019-03-03","kind":"exercise","acquired":true,"shares":3302,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":80874,"source":{"system":"sec-edgar","filing":"0001225208-19-004340","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520819004340/doc4.xml","form_type":"4"}},{"id":3620830,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Common Stock","published_at":"2019-03-04T21:29:41.000Z","date":"2019-03-01","kind":"sale","acquired":false,"shares":20900,"price":40.7441,"value":851551.69,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $40.74 to $40.76, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":77572,"source":{"system":"sec-edgar","filing":"0001225208-19-004340","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520819004340/doc4.xml","form_type":"4"}},{"id":3633775,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Deferred Stock Units","published_at":"2019-02-26T21:32:04.000Z","date":"2019-02-24","kind":"exercise","acquired":false,"shares":2867,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"expiration_date":"2019-02-24","underlying":"Common Stock","underlying_shares":2867},"source":{"system":"sec-edgar","filing":"0001225208-19-003719","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520819003719/doc4.xml","form_type":"4"}},{"id":3633774,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Deferred Stock Units","published_at":"2019-02-26T21:32:04.000Z","date":"2019-02-23","kind":"exercise","acquired":false,"shares":3679,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant."}],"balance_after":3679,"derivative":{"expiration_date":"2020-02-23","underlying":"Common Stock","underlying_shares":3679},"source":{"system":"sec-edgar","filing":"0001225208-19-003719","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520819003719/doc4.xml","form_type":"4"}},{"id":3633773,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Deferred Stock Units","published_at":"2019-02-26T21:32:04.000Z","date":"2019-02-22","kind":"exercise","acquired":false,"shares":3766,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant."}],"balance_after":7532,"derivative":{"expiration_date":"2021-02-22","underlying":"Common Stock","underlying_shares":3766},"source":{"system":"sec-edgar","filing":"0001225208-19-003719","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520819003719/doc4.xml","form_type":"4"}},{"id":3633772,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Common Stock","published_at":"2019-02-26T21:32:04.000Z","date":"2019-02-24","kind":"tax_withholding","acquired":false,"shares":1308,"price":40.52,"value":53000.16,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":98472,"source":{"system":"sec-edgar","filing":"0001225208-19-003719","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520819003719/doc4.xml","form_type":"4"}},{"id":3633771,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Common Stock","published_at":"2019-02-26T21:32:04.000Z","date":"2019-02-24","kind":"exercise","acquired":true,"shares":2867,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":99780,"source":{"system":"sec-edgar","filing":"0001225208-19-003719","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520819003719/doc4.xml","form_type":"4"}},{"id":3633770,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Common Stock","published_at":"2019-02-26T21:32:04.000Z","date":"2019-02-23","kind":"tax_withholding","acquired":false,"shares":1678,"price":40.52,"value":67992.56,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":96913,"source":{"system":"sec-edgar","filing":"0001225208-19-003719","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520819003719/doc4.xml","form_type":"4"}},{"id":3633769,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Common Stock","published_at":"2019-02-26T21:32:04.000Z","date":"2019-02-23","kind":"exercise","acquired":true,"shares":3679,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":98591,"source":{"system":"sec-edgar","filing":"0001225208-19-003719","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520819003719/doc4.xml","form_type":"4"}},{"id":3633768,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Common Stock","published_at":"2019-02-26T21:32:04.000Z","date":"2019-02-22","kind":"tax_withholding","acquired":false,"shares":1718,"price":40.52,"value":69613.36,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":94912,"source":{"system":"sec-edgar","filing":"0001225208-19-003719","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520819003719/doc4.xml","form_type":"4"}},{"id":3633767,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Common Stock","published_at":"2019-02-26T21:32:04.000Z","date":"2019-02-22","kind":"exercise","acquired":true,"shares":3766,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":96630,"source":{"system":"sec-edgar","filing":"0001225208-19-003719","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520819003719/doc4.xml","form_type":"4"}},{"id":3636930,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-25T23:31:47.000Z","date":"2019-02-21","kind":"grant","acquired":true,"shares":38337,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 21, 2020, the first anniversary of the date of grant."}],"balance_after":38337,"derivative":{"exercise_price":40.12,"expiration_date":"2029-02-21","underlying":"Common Stock","underlying_shares":38337},"source":{"system":"sec-edgar","filing":"0001225208-19-003559","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520819003559/doc4.xml","form_type":"4"}},{"id":3636929,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Deferred Stock Units","published_at":"2019-02-25T23:31:47.000Z","date":"2019-02-21","kind":"grant","acquired":true,"shares":11839,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 21, 2020, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 21, 2020, the first anniversary of the date of grant."}],"balance_after":11839,"derivative":{"expiration_date":"2023-02-21","underlying":"Common Stock","underlying_shares":11839},"source":{"system":"sec-edgar","filing":"0001225208-19-003559","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520819003559/doc4.xml","form_type":"4"}},{"id":3640051,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Performance Share Units","published_at":"2019-02-22T23:11:39.000Z","date":"2019-02-20","kind":"grant","acquired":true,"shares":19038,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each performance share unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"shares","element":"transactionShares","label":"F4","text":"On February 12, 2018, the reporting person was awarded a target number of performance share units under the Company's 2018 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person would be based on the Company's 2018 adjusted free cash flow measured against its 2018 financial plan over the one-year performance period ending December 31, 2018 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 20, 2019, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined will vest in whole upon the completion of the individual service period that ends on December 31, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On February 12, 2018, the reporting person was awarded a target number of performance share units under the Company's 2018 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person would be based on the Company's 2018 adjusted free cash flow measured against its 2018 financial plan over the one-year performance period ending December 31, 2018 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 20, 2019, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined will vest in whole upon the completion of the individual service period that ends on December 31, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On February 12, 2018, the reporting person was awarded a target number of performance share units under the Company's 2018 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person would be based on the Company's 2018 adjusted free cash flow measured against its 2018 financial plan over the one-year performance period ending December 31, 2018 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 20, 2019, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined will vest in whole upon the completion of the individual service period that ends on December 31, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"On February 12, 2018, the reporting person was awarded a target number of performance share units under the Company's 2018 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person would be based on the Company's 2018 adjusted free cash flow measured against its 2018 financial plan over the one-year performance period ending December 31, 2018 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 20, 2019, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined will vest in whole upon the completion of the individual service period that ends on December 31, 2020."}],"balance_after":19038,"derivative":{"exercise_date":"2020-12-31","expiration_date":"2020-12-31","underlying":"Common Stock","underlying_shares":19038},"source":{"system":"sec-edgar","filing":"0001225208-19-003433","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520819003433/doc4.xml","form_type":"4"}},{"id":3640050,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Common Stock","published_at":"2019-02-22T23:11:39.000Z","date":"2019-02-20","kind":"tax_withholding","acquired":false,"shares":16758,"price":40.11,"value":672163.38,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":92864,"source":{"system":"sec-edgar","filing":"0001225208-19-003433","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520819003433/doc4.xml","form_type":"4"}},{"id":3640049,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Common Stock","published_at":"2019-02-22T23:11:39.000Z","date":"2019-02-20","kind":"grant","acquired":true,"shares":37658,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 22, 2016, the reporting person was awarded a target number of performance share units under the Company's 2016 Total Shareholder Return Performance Share Program, the actual number of which to be earned by the reporting person would be based on the Company's total shareholder return performance percentile relative to that of the other companies in the S&P 500 Healthcare Index over the three annual performance cycles comprising the three-year period ended December 31, 2018 and subject to the completion of the concurrent three-year individual service period. On February 20, 2019, the number of the target performance share units as to which the performance criteria had been satisfied was determined and the individual service period was satisfied."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":109622,"source":{"system":"sec-edgar","filing":"0001225208-19-003433","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520819003433/doc4.xml","form_type":"4"}},{"id":3651734,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Deferred Stock Units","published_at":"2019-02-19T23:14:33.000Z","date":"2019-02-15","kind":"exercise","acquired":false,"shares":3229,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant."}],"balance_after":12920,"derivative":{"expiration_date":"2023-02-15","underlying":"Common Stock","underlying_shares":3229},"source":{"system":"sec-edgar","filing":"0001225208-19-002977","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520819002977/doc4.xml","form_type":"4"}},{"id":3651733,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Common Stock","published_at":"2019-02-19T23:14:33.000Z","date":"2019-02-15","kind":"tax_withholding","acquired":false,"shares":989,"price":40.01,"value":39569.89,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":71964,"source":{"system":"sec-edgar","filing":"0001225208-19-002977","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520819002977/doc4.xml","form_type":"4"}},{"id":3651732,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Common Stock","published_at":"2019-02-19T23:14:33.000Z","date":"2019-02-15","kind":"exercise","acquired":true,"shares":3229,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":72953,"source":{"system":"sec-edgar","filing":"0001225208-19-002977","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520819002977/doc4.xml","form_type":"4"}},{"id":3706071,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Common Stock","published_at":"2019-01-04T21:12:52.000Z","date":"2019-01-03","kind":"sale","acquired":false,"shares":12600,"price":33.5507,"value":422738.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $33.05 to $34.04, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":69623,"source":{"system":"sec-edgar","filing":"0001225208-19-000576","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520819000576/doc4.xml","form_type":"4"}},{"id":3706070,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Common Stock","published_at":"2019-01-04T21:12:52.000Z","date":"2019-01-03","kind":"sale","acquired":false,"shares":2140,"price":34.2127,"value":73215.178,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $34.10 to $34.29, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":82223,"source":{"system":"sec-edgar","filing":"0001225208-19-000576","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520819000576/doc4.xml","form_type":"4"}},{"id":3710874,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Performance Share Units","published_at":"2019-01-03T21:55:14.000Z","date":"2019-01-01","kind":"exercise","acquired":false,"shares":21502,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each performance share unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"On February 22, 2016, the reporting person was awarded a target number of performance share units under the Company's 2016 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person based on the Company's 2016 adjusted free cash flow measured against its 2016 financial plan over the one-year performance period ending December 31, 2016 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 28, 2017, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined vested in whole upon the completion of the individual service period that ends on December 31, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On February 22, 2016, the reporting person was awarded a target number of performance share units under the Company's 2016 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person based on the Company's 2016 adjusted free cash flow measured against its 2016 financial plan over the one-year performance period ending December 31, 2016 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 28, 2017, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined vested in whole upon the completion of the individual service period that ends on December 31, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On February 22, 2016, the reporting person was awarded a target number of performance share units under the Company's 2016 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person based on the Company's 2016 adjusted free cash flow measured against its 2016 financial plan over the one-year performance period ending December 31, 2016 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 28, 2017, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined vested in whole upon the completion of the individual service period that ends on December 31, 2018."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2018-12-31","expiration_date":"2018-12-31","underlying":"Common Stock","underlying_shares":21502},"source":{"system":"sec-edgar","filing":"0001225208-19-000433","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520819000433/doc4.xml","form_type":"4"}},{"id":3710873,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Common Stock","published_at":"2019-01-03T21:55:14.000Z","date":"2019-01-01","kind":"tax_withholding","acquired":false,"shares":6762,"price":35.34,"value":238969.08,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":84363,"source":{"system":"sec-edgar","filing":"0001225208-19-000433","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520819000433/doc4.xml","form_type":"4"}},{"id":3710872,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Common Stock","published_at":"2019-01-03T21:55:14.000Z","date":"2019-01-01","kind":"exercise","acquired":true,"shares":21502,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"On February 22, 2016, the reporting person was awarded a target number of performance share units under the Company's 2016 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person based on the Company's 2016 adjusted free cash flow measured against its 2016 financial plan over the one-year performance period ending December 31, 2016 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 28, 2017, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined vested in whole upon the completion of the individual service period that ends on December 31, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":91125,"source":{"system":"sec-edgar","filing":"0001225208-19-000433","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520819000433/doc4.xml","form_type":"4"}},{"id":3710871,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Common Stock","published_at":"2019-01-03T21:55:14.000Z","date":"2018-11-06","kind":"gift","acquired":false,"shares":2385,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":69623,"source":{"system":"sec-edgar","filing":"0001225208-19-000433","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520819000433/doc4.xml","form_type":"4"}},{"id":3710870,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Performance Share Units","published_at":"2019-01-03T14:06:28.000Z","date":"2017-02-28","kind":"grant","acquired":true,"shares":21502,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance share unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"On February 22, 2016, the reporting person was awarded a target number of performance share units under the Company's 2016 Free Cash Flow Performance Share Program, the actual number of which is to be earned by the reporting person based on the Company's 2016 adjusted free cash flow measured against its 2016 financial plan over the one-year performance period ending December 31, 2016 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 28, 2017, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined will vest in whole upon the completion of the individual service period that ends on December 31, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On February 22, 2016, the reporting person was awarded a target number of performance share units under the Company's 2016 Free Cash Flow Performance Share Program, the actual number of which is to be earned by the reporting person based on the Company's 2016 adjusted free cash flow measured against its 2016 financial plan over the one-year performance period ending December 31, 2016 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 28, 2017, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined will vest in whole upon the completion of the individual service period that ends on December 31, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On February 22, 2016, the reporting person was awarded a target number of performance share units under the Company's 2016 Free Cash Flow Performance Share Program, the actual number of which is to be earned by the reporting person based on the Company's 2016 adjusted free cash flow measured against its 2016 financial plan over the one-year performance period ending December 31, 2016 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 28, 2017, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined will vest in whole upon the completion of the individual service period that ends on December 31, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On February 22, 2016, the reporting person was awarded a target number of performance share units under the Company's 2016 Free Cash Flow Performance Share Program, the actual number of which is to be earned by the reporting person based on the Company's 2016 adjusted free cash flow measured against its 2016 financial plan over the one-year performance period ending December 31, 2016 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 28, 2017, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined will vest in whole upon the completion of the individual service period that ends on December 31, 2018."}],"balance_after":21502,"derivative":{"exercise_date":"2018-12-31","expiration_date":"2018-12-31","underlying":"Common Stock","underlying_shares":21502},"source":{"system":"sec-edgar","filing":"0001225208-19-000172","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520819000172/doc4a.xml","form_type":"4/A","original_submission_date":"2017-03-06"}},{"id":3808593,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-09-25T20:01:57.000Z","date":"2018-09-24","kind":"exercise","acquired":false,"shares":37430,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"exercise_price":7.39,"expiration_date":"2023-02-28","underlying":"Common Stock","underlying_shares":37430},"source":{"system":"sec-edgar","filing":"0001225208-18-013738","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520818013738/doc4.xml","form_type":"4"}},{"id":3808592,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Common Stock","published_at":"2018-09-25T20:01:57.000Z","date":"2018-09-24","kind":"sale","acquired":false,"shares":37430,"price":38,"value":1422340.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":72008,"source":{"system":"sec-edgar","filing":"0001225208-18-013738","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520818013738/doc4.xml","form_type":"4"}},{"id":3808591,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Common Stock","published_at":"2018-09-25T20:01:57.000Z","date":"2018-09-24","kind":"exercise","acquired":true,"shares":37430,"price":7.39,"value":276607.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":109438,"source":{"system":"sec-edgar","filing":"0001225208-18-013738","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520818013738/doc4.xml","form_type":"4"}},{"id":3896020,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-13T20:17:35.000Z","date":"2018-06-11","kind":"exercise","acquired":false,"shares":37430,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant."}],"balance_after":37430,"derivative":{"exercise_price":7.39,"expiration_date":"2023-02-28","underlying":"Common Stock","underlying_shares":37430},"source":{"system":"sec-edgar","filing":"0001225208-18-010615","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520818010615/doc4.xml","form_type":"4"}},{"id":3896019,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-13T20:17:35.000Z","date":"2018-06-11","kind":"exercise","acquired":false,"shares":31056,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2012, the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"exercise_price":7.16,"expiration_date":"2021-02-28","underlying":"Common Stock","underlying_shares":31056},"source":{"system":"sec-edgar","filing":"0001225208-18-010615","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520818010615/doc4.xml","form_type":"4"}},{"id":3896018,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Common Stock","published_at":"2018-06-13T20:17:35.000Z","date":"2018-06-11","kind":"sale","acquired":false,"shares":36730,"price":35.8702,"value":1317512.446,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $35.63 to $36.445, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":71151,"source":{"system":"sec-edgar","filing":"0001225208-18-010615","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520818010615/doc4.xml","form_type":"4"}},{"id":3896017,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Common Stock","published_at":"2018-06-13T20:17:35.000Z","date":"2018-06-11","kind":"sale","acquired":false,"shares":31056,"price":32,"value":993792.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":107881,"source":{"system":"sec-edgar","filing":"0001225208-18-010615","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520818010615/doc4.xml","form_type":"4"}},{"id":3896016,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Common Stock","published_at":"2018-06-13T20:17:35.000Z","date":"2018-06-11","kind":"sale","acquired":false,"shares":700,"price":36.77,"value":25739.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":138937,"source":{"system":"sec-edgar","filing":"0001225208-18-010615","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520818010615/doc4.xml","form_type":"4"}},{"id":3896015,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Common Stock","published_at":"2018-06-13T20:17:35.000Z","date":"2018-06-11","kind":"exercise","acquired":true,"shares":31056,"price":7.16,"value":222360.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":139637,"source":{"system":"sec-edgar","filing":"0001225208-18-010615","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520818010615/doc4.xml","form_type":"4"}},{"id":3896014,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Common Stock","published_at":"2018-06-13T20:17:35.000Z","date":"2018-06-11","kind":"exercise","acquired":true,"shares":37430,"price":7.39,"value":276607.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":108581,"source":{"system":"sec-edgar","filing":"0001225208-18-010615","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520818010615/doc4.xml","form_type":"4"}},{"id":3943313,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-08T21:17:11.000Z","date":"2018-05-07","kind":"exercise","acquired":false,"shares":31056,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Grant to the reporting person of an option to purchase 62,112 shares of common stock vesting in four annual increments beginning on February 28, 2012, the first anniversary of the grant."}],"balance_after":31056,"derivative":{"exercise_price":7.16,"expiration_date":"2021-02-28","underlying":"Common Stock","underlying_shares":31056},"source":{"system":"sec-edgar","filing":"0001225208-18-008924","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520818008924/doc4.xml","form_type":"4"}},{"id":3943312,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Common Stock","published_at":"2018-05-08T21:17:11.000Z","date":"2018-05-07","kind":"sale","acquired":false,"shares":31056,"price":30,"value":931680.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":71151,"source":{"system":"sec-edgar","filing":"0001225208-18-008924","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520818008924/doc4.xml","form_type":"4"}},{"id":3943311,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Common Stock","published_at":"2018-05-08T21:17:11.000Z","date":"2018-05-07","kind":"exercise","acquired":true,"shares":31056,"price":7.16,"value":222360.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":102207,"source":{"system":"sec-edgar","filing":"0001225208-18-008924","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520818008924/doc4.xml","form_type":"4"}},{"id":3995375,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-15T20:08:48.000Z","date":"2018-03-14","kind":"exercise","acquired":false,"shares":9375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Grant to the reporting person of an option to purchase a specified number of common stock vesting in four equal annual installments beginning on February 27, 2013, the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"exercise_price":6.28,"expiration_date":"2022-02-27","underlying":"Common Stock","underlying_shares":9375},"source":{"system":"sec-edgar","filing":"0001225208-18-006211","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520818006211/doc4.xml","form_type":"4"}},{"id":3995374,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Common Stock","published_at":"2018-03-15T20:08:48.000Z","date":"2018-03-14","kind":"sale","acquired":false,"shares":33428,"price":28.3097,"value":946336.6516,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $28.17 to $28.51, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":71151,"source":{"system":"sec-edgar","filing":"0001225208-18-006211","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520818006211/doc4.xml","form_type":"4"}},{"id":3995373,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Common Stock","published_at":"2018-03-15T20:08:48.000Z","date":"2018-03-14","kind":"sale","acquired":false,"shares":9375,"price":28.3718,"value":265985.625,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $28.27 to $28.51, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":104579,"source":{"system":"sec-edgar","filing":"0001225208-18-006211","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520818006211/doc4.xml","form_type":"4"}},{"id":3995372,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Common Stock","published_at":"2018-03-15T20:08:48.000Z","date":"2018-03-14","kind":"exercise","acquired":true,"shares":9375,"price":6.28,"value":58875.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":113954,"source":{"system":"sec-edgar","filing":"0001225208-18-006211","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520818006211/doc4.xml","form_type":"4"}},{"id":4012549,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Deferred Stock Units","published_at":"2018-03-06T21:19:29.000Z","date":"2018-03-03","kind":"exercise","acquired":false,"shares":3302,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on March 3, 2018, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on March 3, 2018, the first anniversary of the date of grant."}],"balance_after":13211,"derivative":{"expiration_date":"2022-03-03","underlying":"Common Stock","underlying_shares":3302},"source":{"system":"sec-edgar","filing":"0001225208-18-005419","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520818005419/doc4.xml","form_type":"4"}},{"id":4012548,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Common Stock","published_at":"2018-03-06T21:19:29.000Z","date":"2018-03-03","kind":"tax_withholding","acquired":false,"shares":1506,"price":26.77,"value":40315.62,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":104579,"source":{"system":"sec-edgar","filing":"0001225208-18-005419","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520818005419/doc4.xml","form_type":"4"}},{"id":4012547,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Common Stock","published_at":"2018-03-06T21:19:29.000Z","date":"2018-03-03","kind":"exercise","acquired":true,"shares":3302,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":106085,"source":{"system":"sec-edgar","filing":"0001225208-18-005419","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520818005419/doc4.xml","form_type":"4"}},{"id":4025274,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Deferred Stock Units","published_at":"2018-03-01T21:34:16.000Z","date":"2018-02-28","kind":"exercise","acquired":false,"shares":5751,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"expiration_date":"2018-02-28","underlying":"Common Stock","underlying_shares":5751},"source":{"system":"sec-edgar","filing":"0001225208-18-004938","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520818004938/doc4.xml","form_type":"4"}},{"id":4025273,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Common Stock","published_at":"2018-03-01T21:34:16.000Z","date":"2018-02-28","kind":"tax_withholding","acquired":false,"shares":2623,"price":27.26,"value":71502.98,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":102783,"source":{"system":"sec-edgar","filing":"0001225208-18-004938","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520818004938/doc4.xml","form_type":"4"}},{"id":4025272,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Common Stock","published_at":"2018-03-01T21:34:16.000Z","date":"2018-02-28","kind":"exercise","acquired":true,"shares":5751,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":105406,"source":{"system":"sec-edgar","filing":"0001225208-18-004938","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520818004938/doc4.xml","form_type":"4"}},{"id":4035181,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":41681,"kind":"person","name":"Ballinger Kevin J.","position":1,"cik":"0001566080","reported_name":"Ballinger Kevin J.","relationship":{"officer":true,"officer_title":"EVP & Pres, Interven Cardio"}}],"security":"Deferred Stock Units","published_at":"2018-02-26T22:41:18.000Z","date":"2018-02-24","kind":"exercise","acquired":false,"shares":2867,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant."}],"balance_after":2867,"derivative":{"expiration_date":"2019-02-24","underlying":"Common Stock","underlying_shares":2867},"source":{"system":"sec-edgar","filing":"0001225208-18-004198","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520818004198/doc4.xml","form_type":"4"}}],"next_cursor":"2018-02-26T22:41:18.000000Z,4035181"}